Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

347 ARTÍCULOS , VIENDO DEL 196 AL 210

Greater responsiveness to donepezil in Alzheimer patients with higher levels of acetylcholinesterase based on attention task scores and a donepezil PET study

Kasuya M, Meguro K, Okamura N, Funaki Y, Ishikawa H, Tanaka N, Iwata R, Yanai K.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):113-8. doi: 10.1097/WAD.0b013e3182222bc0.

Memantine and functional communication in Alzheimer's disease: results of a 12-week, international, randomized clinical trial

Saxton J, Hofbauer RK, Woodward M, Gilchrist NL, Potocnik F, Hsu HA, Miller ML, Pejović V, Graham SM, Perhach JL.

J Alzheimers Dis. 2012;28(1):109-18. doi: 10.3233/JAD-2011-110947.

The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis

Hooijmans CR, Pasker-de Jong PC, de Vries RB, Ritskes-Hoitinga M.

J Alzheimers Dis. 2012;28(1):191-209. doi: 10.3233/JAD-2011-111217.

Auditory delta event-related oscillatory responses are decreased in Alzheimer's disease

Yener GG, Güntekin B, Örken DN, Tülay E, Forta H, Başar E.

Behav Neurol. 2012;25(1):3-11. doi: 10.3233/BEN-2012-0344.

Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease

Svedberg MM, Rahman O, Hall H.

Nucl Med Biol. 2012 May;39(4):484-501. doi: 10.1016/j.nucmedbio.2011.10.007. Epub 2012 Jan 5.

Peptides for therapy and diagnosis of Alzheimer's disease

Funke SA, Willbold D.

Curr Pharm Des. 2012;18(6):755-67. doi: 10.2174/138161212799277752.

Resumption of food and fluid intake in Alzheimer's disease with severe apathy following intravenous citalopram

Hellen F, Supprian T, Salamon T, Lange-Asschenfeldt C.

Psychiatry Clin Neurosci. 2012 Feb;66(1):82. doi: 10.1111/j.1440-1819.2011.02294.x.

Nonhuman primate models of Alzheimer-like cerebral proteopathy

Heuer E, Rosen RF, Cintron A, Walker LC.

Curr Pharm Des. 2012;18(8):1159-69. doi: 10.2174/138161212799315885.

Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment

Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M.

Neurodegener Dis. 2012;10(1-4):285-93. doi: 10.1159/000335154. Epub 2012 Feb 10.

Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?

Levy K, Lanctôt KL, Farber SB, Li A, Herrmann N.

Drugs Aging. 2012 Mar 1;29(3):167-179. doi: 10.2165/11599140-000000000-00000.

Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease

Aisen PS, Cummings J, Schneider LS.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006395. doi: 10.1101/cshperspect.a006395.

Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's disease

McLaren DG, Sreenivasan A, Diamond EL, Mitchell MB, Van Dijk KR, Deluca AN, O'Brien JL, Rentz DM, Sperling RA, Atri A.

Neurodegener Dis. 2012;9(4):176-86. doi: 10.1159/000335876. Epub 2012 Mar 27.

Alzheimer's disease 2012: the great amyloid gamble

Marchesi VT.

Am J Pathol. 2012 May;180(5):1762-7. doi: 10.1016/j.ajpath.2012.03.004. Epub 2012 Apr 1.

Ethical issues in Alzheimer's disease: an overview

Leuzy A, Gauthier S.

Expert Rev Neurother. 2012 May;12(5):557-67. doi: 10.1586/ern.12.38.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias